Company intelligence / Profile preview
SynerK PharmaTech
Suzhou, Jiangsu, China
- Ownership
- Private
- Employees
- ~60
- Development stage
- Other
01
Overview
SynerK PharmaTech is a clinical-stage biotechnology company dedicated to the discovery and development of innovative RNA interference (RNAi) therapeutics. The company utilizes its proprietary siRNA platform to create highly specific and potent drugs for chronic diseases, with a primary focus on cardiovascular and metabolic health. SynerK's lead programs leverage advanced GalNAc-conjugation technology for liver-targeted delivery, while the company also advances proprietary extrahepatic delivery solutions for other tissues. With R&D operations in both China and the United States, SynerK is positioned to address global markets with a pipeline of next-generation RNA medicines designed for long-lasting therapeutic effects.
- Therapeutic areas
- CardiovascularMetabolic Disorders
- Modalities
- Small interfering RNARNA therapy
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on SynerK PharmaTech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SynerK PharmaTech.